ESSDAI scores over 24 weeks of treatment with leflunomide–hydroxychloroquine or placebo: (IMAGE)
Caption
ESSDAI scores over 24 weeks of treatment with leflunomide–hydroxychloroquine or placebo:
(A) Mean ESSDAI corrected for baseline, indicating the treatment effect of leflunomide–hydroxychloroquine versus placebo after 8 weeks, 16 weeks, and 24 weeks. Error bars indicate SEM. (B) Within-treatment paired ESSDAI differences between baseline and 24 weeks, with each line representing one patient. p values indicate the difference compared with baseline.
Credit
Lancet Rheumatology
Usage Restrictions
No restrictions
License
Original content